Literature DB >> 26075079

Investigation of the mechanism underlying the antihypertensive effect of catheter-based radiofrequency renal sympathetic denervation in hypertensive dogs.

Fenglin Jiang1, Hui Li1, Fuying Zhu1, Lixiong Zeng1, Xiaoyan Wang1, Xinguo Wang1, Zhijie Shen1, Kan Yang1, Zhihui Zhang1.   

Abstract

The present study aimed to assess the antihypertensive efficacy and safety of catheter-based radiofrequency renal sympathetic denervation (RSD) in hypertensive dogs. Furthermore, the study investigated the possible antihypertensive mechanism of radiofrequency RSD through measuring the postoperative serum concentrations of angiotensin II (AngII), nicotinamide adenine dinucleotide phosphate oxidase (NADPH-ox), malondialdehyde (MDA), nitric oxide (NO) and endothelial NO synthase (eNOS). A total of 12 beagles were randomly divided into the surgery (n=6) and the sham-surgery groups (n=6). The hypertension model was established using a high-fat diet. The surgery group received catheter-based radiofrequency RSD, while the sham-surgery group only received renal arteriography. Blood pressure was measured prior to the surgery and 3 days, 1 and 2 weeks, and 1, 2 and 3 months after the surgery. The serum concentrations of AngII, NADPH-ox, MDA, NO and eNOS were measured prior to the surgery and 1 week, and 1 and 3 months after the surgery. Following the establishment of the model, the systolic arterial pressure (SAP), diastolic arterial pressure (DAP) and mean arterial pressure (MAP) of the surgery and the sham-surgery groups were all significantly increased above the baseline (P<0.05), but there was no significant difference between the two groups. SAP, DAP and MAP in the surgery group at 1 and 3 months after the surgery were significantly decreased compared to the levels measured prior to the surgery and those in the sham-surgery group (P<0.05). Three months after the surgery, the serum creatinine level was normal and renal arteriography did not show renal artery stenosis. Compared to those measured prior to the surgery, the concentrations of serum AngII, NADPH-ox and MDA in the surgery group at 1 week, and 1 and 3 months after the surgery were decreased, while the concentrations of serum NO and eNOS were increased (P<0.05). The above indicators measured at the same time points demonstrated statistically significant differences between the surgery and the sham-surgery groups (P<0.05). In conclusion, catheter-based radiofrequency RSD may inhibit the renin-angiotensin system and the oxidative stress response, as well as improve vascular endothelial function, thus significantly reducing blood pressure through the reduction of sympathetic activity in hypertensive dogs.

Entities:  

Keywords:  catheter-based ablation; endothelial function; hypertension; oxidative stress; renal sympathetic denervation; renin-angiotensin system

Year:  2014        PMID: 26075079      PMCID: PMC4448015          DOI: 10.3892/br.2014.410

Source DB:  PubMed          Journal:  Biomed Rep        ISSN: 2049-9434


  15 in total

Review 1.  ABC of hypertension: The pathophysiology of hypertension.

Authors:  G Beevers; G Y Lip; E O'Brien
Journal:  BMJ       Date:  2001-04-14

Review 2.  Current status of lumbar sympathectomy.

Authors:  T R Allen
Journal:  Am Surg       Date:  1976-02       Impact factor: 0.688

Review 3.  Neurohormonal regulation of the sympathetic nervous system: new insights into central mechanisms of action.

Authors:  Scott H Carlson; J Michael Wyss
Journal:  Curr Hypertens Rep       Date:  2008-06       Impact factor: 5.369

Review 4.  Neural control of renal function.

Authors:  G F DiBona; U C Kopp
Journal:  Physiol Rev       Date:  1997-01       Impact factor: 37.312

5.  Systemic and renal-specific sympathoinhibition in obesity hypertension.

Authors:  Thomas E Lohmeier; Radu Iliescu; Boshen Liu; Jeffrey R Henegar; Christine Maric-Bilkan; Eric D Irwin
Journal:  Hypertension       Date:  2011-12-19       Impact factor: 10.190

6.  Detection of oxidative stress. Interest of GC-MS for malondialdehyde and formaldehyde monitoring.

Authors:  P Maboudou; D Mathieu; H Bachelet; J F Wiart; M Lhermitte
Journal:  Biomed Chromatogr       Date:  2002-05       Impact factor: 1.902

7.  Renal sympathetic denervation suppresses de novo podocyte injury and albuminuria in rats with aortic regurgitation.

Authors:  Kazi Rafiq; Takahisa Noma; Yoshihide Fujisawa; Yasuhiro Ishihara; Yoshie Arai; A H M Nurun Nabi; Fumiaki Suzuki; Yukiko Nagai; Daisuke Nakano; Hirofumi Hitomi; Kento Kitada; Maki Urushihara; Hiroyuki Kobori; Masakazu Kohno; Akira Nishiyama
Journal:  Circulation       Date:  2012-02-10       Impact factor: 29.690

8.  Percutaneous renal denervation in patients with treatment-resistant hypertension: final 3-year report of the Symplicity HTN-1 study.

Authors:  Henry Krum; Markus P Schlaich; Paul A Sobotka; Michael Böhm; Felix Mahfoud; Krishna Rocha-Singh; Richard Katholi; Murray D Esler
Journal:  Lancet       Date:  2013-11-07       Impact factor: 79.321

9.  Prevalence of endothelial nitric oxide synthase E298D polymorphism in Turkish patients with essential hypertension.

Authors:  Figen Esin Kayhan; Meliha Koldemir; Penbe Cagatay; Cavlan Ciftci; Belgin Susleyici-Duman
Journal:  Diabetes Metab Syndr       Date:  2013-03-07

10.  Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study.

Authors:  Henry Krum; Markus Schlaich; Rob Whitbourn; Paul A Sobotka; Jerzy Sadowski; Krzysztof Bartus; Boguslaw Kapelak; Anthony Walton; Horst Sievert; Suku Thambar; William T Abraham; Murray Esler
Journal:  Lancet       Date:  2009-03-28       Impact factor: 79.321

View more
  1 in total

Review 1.  A Perspective on the Delivery of Renal Denervation Therapy Based on Pre-Clinical Data.

Authors:  Armando Tellez; Krista N Dillon; Brad Hubbard; Dane A Brady; Dhanansayan Shanmuganayagam; Serge D Rousselle
Journal:  JACC Basic Transl Sci       Date:  2016-06-27
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.